Gujarat Based-Penny Stock Under Rs 2 Hit Upper Circuit As Board Is Likely To Announce Stock Split
The stock is trading at 0.48 times its book value and the stock is up by 33 per cent from its 52-week low of Rs 1.04 per share.
On Monday, shares of Murae Organisor Limited (Formerly known as Earum Pharmaceuticals Limited) hit a 5 per cent upper circuit to Rs 1.38 per share from its previous closing of Rs 1.32 per share. The stock’s 52-week high is Rs 2.73 per share and its 52-week low is Rs 1.04 per share. The shares of the company saw a spurt in volume by more than 1.10 times on the BSE.
Murae Organisor Limited hereby notifies its shareholders that a meeting of the Board of Directors is scheduled for Thursday, April 24th, 2025, at the company's registered office located at A-1311, Sun West Bank, Ashram Road, Ahmedabad, Gujarat, 380009. The agenda for this meeting includes the consideration and potential approval of a proposal for the sub-division or split of the company's equity shares, the specifics of which will be determined by the Board and are subject to the approval of both the shareholders and relevant authorities.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Murae Organisor Ltd., incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.
The company has a market cap of Rs 128 crore and its 100 per cent stake is owned by public shareholders. The stock is trading at 0.48 times its book value and the stock is up by 33 per cent from its 52-week low of Rs 1.04 per share.
Disclaimer: The article is for informational purposes only and not investment advice.